Medicine by Sfakianakis Alexandros

ClinicalTrials.gov: HEAD AND NECK | Open Studies | updated in the last 14 days

Inoreader - The content reader for power users who want to save time. One place to keep up with all your information sources. Rely on powerful free search, full archive of your subsc...

A Phase 1/2 Study of CYT-0851, an Oral RAD51 Inhibitor, in B-Cell Malignancies and Advanced Solid Tumors

A Phase 1/2 Study of CYT-0851, an Oral RAD51 Inhibitor, in B-Cell Malign... A Phase 1/2 Study of CYT-0851, an Oral RAD51 Inhibitor, in B-Cell Malignancies and Advanced Solid Tumors - Full ...

Conditions:   Malignancy;   Non-hodgkin Lymphoma;   Multiple Myeloma;   Breast Cancer;   Ovarian Cancer;   Soft Tissue Sarcoma;   Squamous Cell Carcinoma;   Head and Neck Cancer;   DLBCL;   Mantle Cell Lymphoma;   Follicular Lymphoma;   Leiomyosarcoma;   Pancreatic Cancer;   Sarcoma;   CLLIntervention:   Drug: CYT-0851Sponsor:   Cyteir Therapeutics, Inc.Not yet recruiting

ClinicalTrials.gov: HEAD AND NECK | Open Studies | updated in the last 14 days

now

Comparing Normal Radiation Treatment Areas to Reduced Treatment Areas in Head and Neck Cancer

Comparing Normal Radiation Treatment Areas to Reduced Treatment Areas in... Comparing Normal Radiation Treatment Areas to Reduced Treatment Areas in Head and Neck Cancer - Full Text View.

Condition:   Head and Neck CancerInterventions:   Radiation: Radiotherapy to all dissected areas;   Radiation: Omit radiation to pN0 neckSponsor:   Lawson Health Research InstituteNot yet recruiting

ClinicalTrials.gov: HEAD AND NECK | Open Studies | updated in the last 14 days

now

ALEXANDROS SFAKIANAKIS ANAPAFSEOS 5 AGIOS NIKOLAOS CRETE 72100 GREECE +306932607174 +302841026182